Pharmaceuticals, Biotechnology and Life Sciences
Further Milestone from Janssen on NDA Approval by the US FDA of BALVERSA™ (erdafitinib) for the Treatment of Urothelial Cancer…
DUBLIN–(BUSINESS WIRE)–The “Cansidas – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Cansidas – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Zactos – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Zactos – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Pulmicort Turbuhaler – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Pulmicort Turbuhaler – Drug Insight,…
DUBLIN–(BUSINESS WIRE)–The “Tarceva – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Tarceva – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Minerva-35 – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Minerva-35 – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Aciphex – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Aciphex – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Selzentry – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Selzentry – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Glivec – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Glivec – Drug Insight, 2019 highlights…
DUBLIN–(BUSINESS WIRE)–The “Caduet – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. Caduet – Drug Insight, 2019 highlights…